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ABSTRACT
Despite a trend of declining consumption, resistance to co-trimoxazole has increased during a 12-year
period in Stockholm. The molecular background to this surprising development was investigated by
using PCR to screen for integrons and speciﬁc resistance genes, followed by sequence analysis of
selected integrons, in 105 clinical urinary isolates of Gram-negative bacteria selected partly for
trimethoprim resistance. Sixty-ﬁve integrons of class 1 or 2 were detected in a subset of 59 isolates, and
of these positive isolates, all but one were resistant to trimethoprim. However, 11 isolates were
resistant to trimethoprim, but negative for integrons. Isolates positive for integrons were resistant to an
average of 4.2 antibiotics, compared with 1.9 antibiotics for integron-negative isolates. Despite this, the
only gene cassettes identiﬁed in 19 class 1 integrons analysed were dfr and aadA cassettes. Thus, only
resistance to trimethoprim, streptomycin, spectinomycin and sulphonamides could be explained by
the presence of integrons in these isolates. A new dfr gene, named dfrA22, was discovered as a single
gene cassette in a class 1 integron. In addition, sulphonamide resistance in many isolates was caused
by carriage of sul2, which has no known association with integrons. Resistance to co-trimoxazole and
many other antibiotics was thus not accounted for fully by the presence of integrons in these isolates.
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INTRODUCTION
Overuse and misuse of antimicrobial agents is
widespread throughout the world. As a result,
resistance rates to available and affordable anti-
microbial agents continue to increase in many
countries for many pathogenic and commensal
bacteria [1–4]. In Sweden, use of antimicrobial
agents is quite restricted, so overuse and misuse is
less frequent than in many other parts of the
world; however, increasing rates of resistance to
many antimicrobial agents have been observed
[5]. In a 12-year investigation at the Karolinska
Hospital in Stockholm, a trend towards rapidly
declining consumption of trimethoprim-sulpha-
methoxazole (co-trimoxazole) associated with
increasing resistance to the same agents was
noted [6]. This development suggests that the
mechanism for selection of the corresponding
resistance genes may not involve simply direct
selection pressure by these drugs. In earlier
studies of the relationship between consumption
of trimethoprim and resistance to the drug,
performed in Finland, no clear correlation could
be established [7]. A decreased consumption of
trimethoprim or co-trimoxazole seemed to have
little immediate effect on the overall resistance
situation.
Streptomycin provides an obvious example of
the slow decline in antimicrobial resistance. This
agent has scarcely been used in human therapy
during the last 20 years, yet resistance levels to
streptomycin remain high in clinical isolates [8].
Similarly, in spite of a dramatic decrease in
sulphonamide consumption in the UK, ascribed
to the restricted prescription of the drug since 1995,
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sulphonamide resistance remains common in clin-
ical isolates of Escherichia coli [9]. It seems probable
that co-selection of antibiotic resistance genes
occurs when many types of antibiotics are used,
but precise knowledge is lacking inmost cases. It is
also possible that other agents, such as heavy
metals and certain types of disinfectants and
antiseptics, could contribute to co-selection, result-
ing in an increase in antimicrobial resistance levels.
Other factors that probably contribute to the
spread of antimicrobial resistance are genetic
elements called integrons. These elements are
capable of insertion, excision and expression of
gene cassettes. Integration and excision of gene
cassettes occur by site-speciﬁc recombination,
catalysed by an integrase, intI, encoded by the
5¢-conserved segment of the integron. This con-
served segment also contains a recombination
site, attI, and a promoter, Pant, which is common
for the entire variable region containing the gene
cassettes [10–12]. Downstream of class 1 integ-
rons, a semiconserved segment containing the
sul1 and qacED1 genes, encoding resistance to
sulphonamides and quaternary ammonium com-
pounds, respectively, can often be found. Integ-
rons can carry many different types of gene
cassettes, and practically all of those so far
characterised are antibiotic resistance genes. At
the present time, >70 different gene cassettes are
known, with up to nine cassettes observed in a
single integron [13,14].
A large group of trimethoprim resistance genes,
clustering in three distinctive structural families,
are found exclusively on cassettes in integrons. A
smaller group of ﬁve genes, dfr3, 4, 8, 9 and 10, has
so far not been found on cassettes. No dfr gene has
been found to alternate between a cassette and a
location elsewhere [15]. All dfr genes encode
trimethoprim-resistant dihydrofolate reductases.
The unusual dihydrofolate reductase genes dfr2a,
2b, 2c and 2d constitute an homologous group of
cassettes which is unrelated to any other dfr genes
and which encodes peptides of 78 amino-acids.
These genes are also called dfrB genes according to
a different nomenclature system [16]. The remain-
ing group of c.20 dihydrofolate reductases (enco-
ded by dfrA genes in the alternative nomenclature)
are around 160 amino-acids in size and share
20–95% identity [13,17,18].
There are only three known genes encoding
resistance to sulphonamides in Gram-negative
bacteria, namely sul1, sul2 and sul3. The ﬁrst gene,
sul1, has been observed only as part of the
3¢-conserved sequence in class 1 integrons, but
sul2 has never been found as part of an integron.
The sul3 gene was ﬁrst reported in E. coli from
pigs in Switzerland in 2003. It has also been
described in E. coli from pigs, cattle and poultry
in Germany [13,19–22].
The aim of the present study was to investi-
gate the molecular background of the increasing
resistance to trimethoprim and sulphamethoxaz-
ole in a collection of clinical urinary isolates of
Gram-negative bacteria. Following the observa-
tion of a new dfr2 gene and the sul3 gene in the
same collection [23,24], the decision was taken
to investigate the molecular characteristics of




The study investigated 105 clinical urinary isolates of Gram-
negative bacteria collected during May and June 2001 at the
Department of Clinical Microbiology, Karolinska Hospital,
Stockholm. Of these, 71 were consecutive trimethoprim-resist-
ant or intermediately-resistant isolates, while the remaining
34 were consecutive trimethoprim-susceptible isolates. The
isolates were identiﬁed initially by standard biochemical tests
and were tested for resistance to trimethoprim by disk
diffusion [25] using Isosensitest agar and antibiotic disks
(Oxoid AB, Sollentuna, Sweden). Zone breakpoints used
for determining trimethoprim sensitivity and resistance were
17 mm and 13 mm, respectively, as recommended by the
Swedish Reference Group for Antibiotics (SRGA) (http://
www.srga.org) [26,27].
Antibiotic resistance
An extended resistance test was performed by disk diffusion
with disks containing ampicillin 10 lg, trimethoprim 5 lg,
sulphonamides 300 lg (sulphathiazole 111 lg, sulphadiazine
78 lg and sulphamerazine 111 lg), chloramphenicol 30 lg,
cefuroxime 30 lg, amoxycillin 20 lg with clavulanic acid
10 lg, gentamicin 30 lg, streptomycin 10 lg, amikacin 30 lg,
netilmicin 30 lg, kanamycin 30 lg and spectinomycin 25 lg
(Oxoid). Zone breakpoints were those recommended by
SRGA, supplemented with breakpoints from NCCLS for
amoxycillin-clavulanic acid, kanamycin, streptomycin and
sulphonamides [26–28]. Breakpoints for spectinomycin were
established in the laboratory.
PCR
Templates for PCR were made by resuspending a loopful of
bacterial growth in 100 lL of sterile ﬁltered water (Sigma-
Aldrich, Stockholm, Sweden) and boiling for c.2 min, fol-
lowed by a short centrifugation step and storage at )20C
until use. PCR master mixes were prepared according to a
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standard protocol (Perkin Elmer ⁄Wallac Sverige AB, Upp-
lands Va¨sby, Sweden) in which 1.5 lL of template was
added to 24 lL of reaction mixture containing 10 mM
Tris-HCl, 50 mM KCl, 2.5 mM MgCl2 (Applied Biosystems,
Stockholm, Sweden), 200 lM dNTPs (Amersham Biosciences
AB, Uppsala, Sweden), 0.5 lM each primer, and 0.6 U
TaqGold (Applied Biosystems), pH 8.3. Ampliﬁcations were
performed in a GeneAmp PCR System 9700 (Applied
Biosystems) with one cycle of 95C for 10 min, 30 cycles of
94C for 45 s, 64, 51 or 55C (as appropriate) for 45 s and
72C for 2 min, with a ﬁnal extension at 72C for 10 min.
The sequences of the speciﬁc PCR primers and the annealing
temperatures used for different primer pairs are listed in
Table 1.
Amplicons were analysed by electrophoresis on agarose
(NuSieve 3 : 1; BioWhittaker ⁄ In vitro Sweden AB, Stockholm,
Sweden) 0.5, 1.0 or 2.0% w/v gels in TAE buffer (4 mM Tris-
acetate, 1 mM EDTA, pH 8.0) at 100–120 V for 30–55 min.
Molecular size markers used were numbers III, VI, VII and VIII
from Boehringer Mannheim (Scandinavia AB, Bromma,
Sweden). Gels were stained with ethidium bromide and
photographed under UV light. E. coli strains carrying plasmids
pMS128, R67, R483 or R100.1 (Department of Medical Biochem-
istry andMicrobiology,UppsalaUniversity, Sweden)wereused
in all PCR runs as positive controls for integrons of class 1 and 2
and for the sul1 gene, respectively. A sample with no DNA
template was used as a negative control in every batch of PCRs.
Positive controlswere not available for some of the primer pairs;
these PCRs were repeated at several annealing temperatures
and primer concentrations to conﬁrm negative results.
DNA sequence analysis
For sequence analysis, 45 lL of PCR products were ﬁrst
puriﬁed with the Jet quick spin column technique kit or the
Jet quick gel extraction kit (Genomed ⁄ Saveen Werner AB,
Malmo¨, Sweden). Primers used for sequence analysis were
Igr1-f and -r, Igr1-f2 and -r2 and Sul3-f and -r (Table 1). ABI
Prism Big Dye Terminator Cycle Sequencing Ready Reaction
Kits v.2.0 and 1.1 (Applied Biosystems) were used for the
sequencing reactions, with 60 s at 96C, 25 cycles of 96C for
10 s, 50C for 5 s and 60C for 4 min, and a ﬁnal extension
at 60C for 1 min. The sequencing reaction products were
then precipitated according to the ethanol ⁄ sodium acetate or
the ethanol ⁄EDTA precipitation protocols recommended in
the kit, followed by analysis with an ABI Prism 310 Genetic
Analyser (Applied Biosystems).
Selected isolates were ﬁrst sequenced from Igr1-f2 and Igr1-
r2 (Table 1). If the sequences obtained were not clearly
overlapping, new primers were designed for further sequen-
cing reactions (primer walking). The integrons of a few isolates
were also sequenced with primers Igr1-f and Igr1-r (Table 1) to
analyse the non-overlapping sequences at both ends. The raw
sequence data were processed with the Sequencher program
Table 1. Primers used in PCR
screening experiments Primer Locus Sequence (5¢-to 3¢)
Annealing
temp (C) Source
Igr1-f 5¢-CS class 1 integrons
intI
GCT CTA GAC CGA AAC CTT GCG CTC 64 This study
Igr1-r 3¢-CS class 1 integrons
qacED1
GGA ATT CAT GAT ATA TCT CCC AAT TTG T 64 This study
Igr2-f 5¢-CS class 2 integrons GCT CTA GAT AAT GTG CAT CGT GCA AGC 64 This study
Igr2-r 3¢-CS class 2 integrons GCG TTA TCT AGT TCG ACA TAG TCT 64 This study
Igr1-f2 5¢-CS class 1 integrons
close to cassette region
TAC GCC GTG GGT CGA TGT TTG ATG 64 This study
Igr1-r2 3¢-CS class 1 integrons
qacED1 close to
cassette region
CTT GAC CTG ATA GTT TGG CTG TGA 64 This study
IntI1-f 5¢-intI1 CAA CAC ATG CGT GTA AAT 55 [17]
IntI1-r mid-intI1 TGC GGG TCA AGG ATG TGG ATT T 55 [17]
IntI1-r2 3¢-intI1 CTT GCT GCT TGG ATG CC 55 [17]
Sul1-f 5¢-sul1 ATG GTG ACG GTG TTC GGC ATT CTG A 64 This study
Sul1-r 3¢-sul1 CTA GGC ATG ATC TAA CCC TCG GTC T 64 This study
Sul2-f 5¢-sul2 GAA TAA ATC GCT CAT CAT TTT CGG 64 This study
Sul2-r 3¢-sul2 CGA ATT CTT GCG GTT TCT TTC AGC 64 This study
Sul3-f 5¢-sul3 GAG CAA GAT TTT TGG AAT CG 51 [21]
Sul3-f2 mid-sul3 CAT TCT AGA AAA CAG TCG TAG TTC G 51 [21]
Sul3-r 3¢-sul3 CAT CTG CAG CTA ACC TAG GGC TTT GGA 51 [21]
IntI3-f 5¢-integrase class 3 AGT GGG TGG CGA ATG AGT G 50 [31]
IntI3-r 3¢-integrase class 3 TGT TCT TGT ATC GGC AGG TG 50 [31]
Igr4-f 5¢-intI9 GTC TCA AGT AAC ACC ACT TCG AT 60 This study
Igr4-r 3¢-intI9 ATT ATC GGT CTA TAG GGC TAA TTG 60 This study
Dfr2d-f 5¢-dfr2d TTG GGC TTC ACC AGA GTA TCA AGT T 64 This study
Dfr2d-r 3¢-dfr2d GCT GTG GAC GGT GCC GCA TGA TTT G 64 This study
Dfr3-f 5¢-dfr3 ATG TTG ATT TCT TTG ATT GC 44 This study
Dfr3-r 3¢-dfr3 GAC TCA AGG TAA CAA AT 44 This study
Dfr8–3 5¢-dfr8 ACG GCG CTA TCT TCG TGA ACA ACG 58 [18]
Dfr8–4 3¢-dfr8 TCT TCC ATG CCA TTC TGC TCG TAG 58 [18]
IS26-p3 IS26 element 5¢-dfr8 GAT CCC CTG GGC GAA ATG CGC CTG 58 [18]
Dfr9-f 5¢-dfr9 TAA GAC AGG AGG TAT CGG A 47 This study
Dfr9-r 3¢-dfr9 TGG GTT CCT CAC TAA TA 47 This study
Dfr10-f 5¢-dfr10 TAT CAC TTA TCT TTG CCA 50 This study
Dfr10-r 3¢-dfr10 GGC ACC CCA ACC AGC GAA 50 This study
QacE-f1 5¢-qacE GGC TGG CTT TTT CTT GTT ATC 55 This study
QacE-f2 mid-qacE TGA AAT CCA TCC CTG TCG GTG TTG CTT 55 This study
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(Gene Codes Corporation, Ann Arbor, MI, USA). Subsequent




Table 2 lists the antibiotic susceptibilities of the
105 isolates included in the study. Since the
isolates were selected in part on the basis of
trimethoprim resistance, the ﬁgures do not rep-
resent the typical resistance levels found among
urinary isolates in the Karolinska hospital. How-
ever, in addition to trimethoprim and sulphon-
amide resistance, resistance levels to ampicillin,
streptomycin, chloramphenicol and spectinomy-
cin were relatively high.
PCR screening for integrons
In total, 65 integrons were detected in 59 isolates
(Table 3). Class 1 integrons were more common
than class 2 integrons. Of the 59 isolates, 37
carried a single class 1 integron, three carried
two class 1 integrons, three carried one class 1
integron and one class 2 integron, and seven
carried a single class 2 integron. In addition to
these 56 integrons which included a gene-cassette
region, nine isolates were positive for the class 1
integrase, and were therefore also considered to
be positive for class 1 integrons. No class 3 or
class 4 integrons were found.
The ampliﬁcation products of class 1 integrons
varied in size between 1 and 2 kb, with three
clusters of c.1.05 kb, 1.3 kb and 1.8 kb, while those
of class 2 integrons were all of c.2.7 kb (corres-
ponding to the total size of the three gene
cassettes known to be most prevalent in con-
served class 2 integrons and the associated 5¢-and
3¢ segments ampliﬁed by the primers). No con-
clusions could be drawn regarding the distribu-
tion of integrons among different bacterial species
since there were relatively few isolates of species
other than E. coli.
Relationship between integrons and
antimicrobial resistance
All the isolates positive for integrons, except one,
were resistant to trimethoprim, and all isolates
carrying a class 1 integron, except two, were also
resistant to sulphonamides. No fully susceptible
isolate was integron-positive. Of the 105 isolates
tested, 53were resistant to four ormore antibiotics,
but only nine of these isolates were of a species
other than E. coli. Of these 53 isolates, 43 were
integron-positive; thus ten isolates remained that
were resistant to at least four antimicrobials and
were integron-negative. Overall, isolates that were
integron-negative expressed resistance to an aver-
age of 1.9 antimicrobial agents, while integron-
positive isolates were resistant to an average of
4.2 of the 12 antimicrobial agents tested.
Eleven isolates were resistant to trimethoprim
and integron-negative, and PCRs for dfr3, 8, 9 and
10, i.e., four of the ﬁve dfr genes not known to
form part of gene cassettes, were also negative
(the sequence of the dfr4 gene has not yet been
published and it was therefore not possible to
design a PCR for this gene). Thus, the molecular
basis of trimethoprim resistance in these 11
isolates remained unexplained.
Sulphonamide resistance and sul genes
Of 66 sulphonamide-resistant isolates (Table 2),
36 carried a sul1 gene, in connection with a class 1
Table 2. Antibiotic disk susceptibilities of the 105 clinical
isolates of Gram-negative bacteria included in the study
AMP TRI SUL CHL CXM ACL GEN STR AMI NET KAN SPE
S 5 34 38 77 90 74 99 48 102 101 95 73
I 33 2 1 3 3 18 2 8 2 4 1 8
R 67 69 66 25 12 13 4 49 1 0 9 24
Total 105 105 105 105 105 105 105 105 105 105 105 105
S, susceptible; I, intermediate resistance; R, resistant. AMP, ampicillin; TRI
trimethoprim; SUL, sulphonamides; CHL, chloramphenicol; CXM, cefuroxime;
ACL, amoxycillin plus clavulanic acid; GEN, gentamicin; STR, streptomycin; AMI,
amikacin; NET, netilmicin; KAN, kanamycin; SPE, spectinomycin.
Table 3. Carriage of integrons by clinical isolates belong-








Escherichia coli 75 51 49 8




Proteus mirabilis 8 3 2 1
Proteus vulgaris 1




Providentia rettgeri 1 1 1
Hafnia alvei 1
Total 105 59 55 10
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integron, and 45 carried a sul2 gene, with 25
isolates positive for both sul1 and sul2. Four
isolates were sulphonamide-resistant and negat-
ive for both sul1 and sul2. These four isolates were
tested by PCR for the sul3 gene, which was
discovered recently in E. coli isolates from pigs in
Switzerland [21]. Two of these four isolates were
positive [24], but the remaining 64 isolates were
negative. Thus two isolates remained that were
sulphonamide-resistant and negative for all three
known sul genes.
One isolate was positive for sul1, but negative
by PCR with three different primer-pairs speciﬁc
for class 1 integrons. Apart from sulphonamides
and trimethoprim, this isolate was also resistant
to ampicillin, chloramphenicol, streptomycin and
spectinomycin, piperacillin, norﬂoxacin and
ciproﬂoxacin. PCR with a forward primer speciﬁc
for qacE and a reverse primer speciﬁc for sul1 was
positive, and the size of the ampliﬁed product
corresponded to the expected size of the sequence
and that of the positive control isolate with an
intact 3¢ integron sequence.
Sequence analysis
Gene cassettes containing known dfr genes are
in the size range 380–620 bp, while cassettes
containing aad genes mediating resistance to
aminoglycosides have sizes of 590–860 bp [13].
The integron cassette regions found in the present
study had sizes consistent with the resistance
patterns conferred upon their hosts, with the
exception of 19 integrons in 18 isolates which
were selected for sequence analysis. Seven differ-
ent dfr genes, three different aadA genes and one
orf cassette were found, but no other gene cas-
settes conferring resistance to other antimicrobial
agents were identiﬁed. The clusters of integron
PCR products (1.05 kb, 1.3 kb and 1.8 kb) corres-
ponded to integrons carrying a dfr gene cassette,
an aadA gene cassette, and a combined dfr and
aadA gene cassette, respectively (Fig. 1).
Two of the gene cassettes revealed previously
unknown sequences. The ﬁrst was a homologue
to the group of dfr2 gene cassettes. This new gene
was designated dfr2d (alternatively, dfrB4; EMBL
accession no. AJ429132) and appeared as a single
cassette in the integron [23]. The second new gene
was also detected as a single gene cassette in a
class 1 integron and was named dfr22. This gene
(dfrA22 according to an alternative nomenclature;
EMBL accession no. AJ628423) was c.93% iden-
tical to dfr13 and belongs to the small sub-
group which previously contained only dfr12
and dfr13.
DISCUSSION
Antibiotic resistance levels among Gram-negative
bacteria in Sweden are fairly low compared with
levels in many other parts of the world [3],
possibly indicating that resistance-mediating ele-
ments occur less frequently. However, an increase
in resistance to co-trimoxazole in E. coli has been
observed in Sweden, despite a decrease in the use
of co-trimoxazole during the same period. The
present study therefore investigated 105 clinical
urinary isolates of Gram-negative bacteria with
respect to their antimicrobial resistance and the
molecular basis for this resistance. Trimethoprim
and sulphonamide resistance in the isolates could,
in many cases, be explained by the presence of
integrons carrying dfr gene cassettes and sul
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                aadA2
U45
                aadA1
U45
                aadA5
dfr12 orfX       aadA2 U67, U80
Fig. 1. Structures of 19 integrons subjected to sequence
analysis. The 5¢ region of the class 1 integrons consists of
the integrase gene intI1, the common promoter Pant, and
the recombination site attI. Every gene cassette also carries
a recombination sequence termed attC. The 3¢ region
usually consists of the genes qacED1 and sul1, as well as the
open reading frame orfX.
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genes. However, 11 isolates expressed trimetho-
prim resistance encoded by unidentiﬁed genes,
and ten of the isolates that were negative for
integron carriage expressed resistance to at least
four antibiotics. This result was in contrast to the
observation that isolates carrying integrons are
usually resistant to twice as many antibiotics as
isolates not carrying integrons. These phenomena
could be explained by a failure of the PCR to
recognise integrons containing dfr genes and
other genes present in the isolates, perhaps
because of changes in the primer target sites, or
it is possible that the trimethoprim resistance was
encoded by unknown dfr genes not carried by
integrons.
Sequence analysis identiﬁed different dfr and
aadA gene cassettes (Fig. 1). This variation in
dfr and aadA gene cassettes, and the variation in
antibiograms observed (results not shown), con-
ﬁrmed that clonal spread was not causing the
observed increase in resistance. Only resistance to
trimethoprim, spectinomycin, streptomycin and
sulphonamides was shown to be integron-
mediated. It was surprising that no antibiotic
resistance gene cassettes, other than dfr and aadA,
were identiﬁed in the 19 integrons analysed by
sequencing.
Selective pressure from one antibiotic can sim-
ultaneously select for genes mediating resistance
to other antibiotics when they are physically
linked, e.g., in the form of gene cassettes in
integrons. This was thought to be responsible for
the increasing resistance to trimethoprim and
sulphamethoxazole, since the combination of
these two drugs is no longer used to a great
extent. The genes conferring the resistance, dfr and
sul, are often linked in the widely distributed
integrons of class 1. Trimethoprim is still used for
the treatment of urinary tract infection, but is often
replaced by other drugs, such as nitrofurantoin,
ﬂuoroquinolones and cephalosporins [29,30].
According to the model of Austin et al. [31], the
current consumption of trimethoprim might be
sufﬁcient to maintain levels of trimethoprim and
sulphamethoxazole resistance, and possibly cause
a further increase in resistance. Continued select-
ive pressure by a constant consumption has been
shown to be enough for a sigmoid rise in resist-
ance levels, which then explains a further rise
before the resistance stabilises at an equilibrium
level. Unfortunately, the delayed resistance
response curve, according to this theory, does
not suggest that an equally fast reduction in
resistance levels will occur following a decline in
the overall amount of drug used. Experimental
studies in Finland and the UK have yielded the
same result [7,9,31], and it seems that if the ‘ﬁtness
cost’ of resistance is sufﬁciently low, even rather
modest consumption of an antibiotic can cause an
overall increase in resistance to the drug in society
as a whole [32]. Integrons still carry, and often
express, aadA gene cassettes which confer resist-
ance to streptomycin and spectinomycin, antibi-
otics that are used only rarely in human medicine
at present. Integrons have a capability to excise
gene cassettes which are not useful for the host
bacterial cell, but these cassettes remain stable in
many bacterial isolates. This suggests that carriage
of integron-borne resistance gene cassettes does
not impose a signiﬁcant burden on the bacteria.
Despite the above observations, the total sul-
phonamide consumption in humans in Sweden is
probably insufﬁcient to drive an increase in
sulphonamide resistance. In this and a previous
study [9], a signiﬁcant proportion of the sulphon-
amide resistance observed was conferred by the
acquisition of sul2 genes which have no known
connection to integrons and dfr genes [9]. The
observed increase in co-trimoxazole resistance
can therefore not be ascribed solely to trimetho-
prim consumption. Veterinary use of these drugs
and the appearance of a third sul gene are
possible clues to the complex mechanisms behind
the continued increase in sulphonamide resist-
ance. However, integrons are also linked to other
resistance elements. Remarkably, properties that
are not encoded by integron-borne gene cassettes
also seem to be more prevalent among integron-
carrying isolates as compared with those devoid
of integrons. One such example is quinolone
resistance, which is known to be caused mainly
by chromosomal mutations, and yet still seems to
be more common in isolates that also carry an
integron [33,34]. Additionally, there seems to be a
correlation between the presence of integrons and
resistance to a greater number of antibiotics
[14,34,35]. Since the integrons analysed in the
present study did not contain gene cassettes
conferring resistance to all the other different
types of antibiotics to which the isolates were
resistant, such resistance genes might be co-
selected with the integrons in another way. The
3¢ end of some class 1 integrons contains a region
where genes which do not constitute gene
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cassettes have been acquired by an unknown
mechanism. For example, the sul1 gene seems to
be inserted stably in the 3¢-end of integrons
without any trace of a cassette structure in its
genetic surroundings.
Overall, it seems that the continued rise in
trimethoprim and sulphonamide resistance might
be ascribed partly to a correlated spread of
resistance genes caused by the selective pressure
of antibiotics and the genetic linkage of integrons
and the resistance genes they contain to other
resistance-mediating elements. However, integ-
rons are not always situated on plasmids, and
plasmids are not always transferred easily
between bacterial strains; indeed, very little is
known about the spread of resistance elements
in vivo. Thus, contrary to expectations and despite
the identiﬁcation ofmany integrons in the resistant
isolates studied, no linkages of resistance genes
were detected in integrons that could account for
co-selection of co-trimoxazole resistance following
the use of other antibacterial agents.
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